NCT02260830View on ClinicalTrials.gov

Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

March 31, 2015

Conditions
Schizophrenia
Interventions
DRUG

Lu AF11167

Trial Locations (1)

Unknown

Quotient Clinical, Nottingham

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT02260830 - Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167 | Biotech Hunter | Biotech Hunter